Members Riobard Posted September 7, 2022 Members Posted September 7, 2022 Erratum above: should be ignore the hatch between the first two vertical bars. Quote
Mavica Posted September 12, 2022 Posted September 12, 2022 Cross-posted here and at The Beer Bar forum: Quote ... Brazil, which, according to the World Health Organization, has close to 10 percent of global monkeypox cases, currently has no vaccine or treatment either. The NY Times is featuring a report in today's (09.12.2022) online edition (a subscription may be required to read the article in its entirety). The report discusses more than just Brazil. https://www.nytimes.com/2022/09/12/health/monkeypox-vaccines-treatments-equity.html Quote
Members Riobard Posted September 12, 2022 Members Posted September 12, 2022 1 hour ago, Mavica said: Cross-posted here and at The Beer Bar forum: The NY Times is featuring a report in today's (09.12.2022) online edition (a subscription may be required to read the article in its entirety). The report discusses more than just Brazil. https://www.nytimes.com/2022/09/12/health/monkeypox-vaccines-treatments-equity.html It appears to be more dire than that, but this point in time may not reflect the future. Cumulative to date is not as relevant a share of global count and higher case accumulations tend to be associated with subsequent drops in incidence. Brazil’s current rolling incidence is trending at 18% of the total global new incidence. However, the ratio is driven by declining incidence elsewhere. The trend has been for new case incidence to hover at a peak and then drop, irrespective of vaccine access. Brazil’s incidence has held steady for 6 weeks following an earlier rapid 10-fold increase. Fingers crossed for them. Obviously vaccine inequity has played a part and administration of MVA-BN would help either prevent incidence increases or drop the curve more quickly than is tentatively predicted. Quote
